annual ROE:
-61.90%+7.22%(+10.45%)Summary
- As of today (July 4, 2025), RXRX annual return on equity is -61.90%, with the most recent change of +7.22% (+10.45%) on December 31, 2024.
- During the last 3 years, RXRX annual ROE has risen by +48.89% (+44.13%).
- RXRX annual ROE is now -224.30% below its all-time high of 49.80%, reached on December 31, 2019.
Performance
RXRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-82.61%-5.55%(-7.20%)Summary
- As of today (July 4, 2025), RXRX quarterly return on equity is -82.61%, with the most recent change of -5.55% (-7.20%) on March 31, 2025.
- Over the past year, RXRX quarterly ROE has dropped by -2.19% (-2.72%).
- RXRX quarterly ROE is now -282.73% below its all-time high of 45.21%, reached on March 31, 2021.
Performance
RXRX quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
RXRX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.4% | -2.7% |
| 3 y3 years | +44.1% | -59.6% |
| 5 y5 years | -224.3% | - |
RXRX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.0% | +44.1% | -91.8% | at low |
| 5 y | 5-year | -224.3% | +44.1% | -282.7% | +54.7% |
| alltime | all time | -224.3% | +44.1% | -282.7% | +54.7% |
RXRX ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | -82.61%(+7.2%) |
| Dec 2024 | -61.90%(-10.4%) | -77.06%(-1.6%) |
| Sep 2024 | - | -78.32%(-1.6%) |
| Jun 2024 | - | -79.57%(-1.1%) |
| Mar 2024 | - | -80.42%(+12.1%) |
| Dec 2023 | -69.12%(+48.5%) | -71.74%(+8.4%) |
| Sep 2023 | - | -66.16%(+12.5%) |
| Jun 2023 | - | -58.81%(+5.7%) |
| Mar 2023 | - | -55.66%(+9.1%) |
| Dec 2022 | -46.56% | -51.00%(+1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -50.16%(+16.5%) |
| Jun 2022 | - | -43.06%(-16.8%) |
| Mar 2022 | - | -51.76%(-25.3%) |
| Dec 2021 | -110.79%(-362.7%) | -69.30%(-5.6%) |
| Sep 2021 | - | -73.43%(-59.8%) |
| Jun 2021 | - | -182.54%(-503.8%) |
| Mar 2021 | - | 45.21%(+7.2%) |
| Dec 2020 | 42.18%(-15.3%) | - |
| Dec 2020 | - | 42.18% |
| Dec 2019 | 49.80% | - |
FAQ
- What is Recursion Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual ROE year-on-year change?
- What is Recursion Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly ROE year-on-year change?
What is Recursion Pharmaceuticals annual return on equity?
The current annual ROE of RXRX is -61.90%
What is the all time high annual ROE for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual return on equity is 49.80%
What is Recursion Pharmaceuticals annual ROE year-on-year change?
Over the past year, RXRX annual return on equity has changed by +7.22% (+10.45%)
What is Recursion Pharmaceuticals quarterly return on equity?
The current quarterly ROE of RXRX is -82.61%
What is the all time high quarterly ROE for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly return on equity is 45.21%
What is Recursion Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, RXRX quarterly return on equity has changed by -2.19% (-2.72%)